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Nitric oxideThe active site of the bacterial nitric oxide reductase from Paracoccus denitriﬁcans contains a dinuclear centre
comprising heme b3 and non heme iron (FeB). These metal centres are shown to be at isopotential with
midpoint reduction potentials of Em≈+80 mV. The midpoint reduction potentials of the other two metal
centres in the enzyme, heme c and heme b, are greater than the dinuclear centre suggesting that they act as an
electron receiving/storage module. Reduction of the low-spin heme b causes structural changes at the
dinuclear centre which allow access to substrate molecules. In the presence of the substrate analogue, CO, the
midpoint reduction potential of heme b3 is raised to a region similar to that of heme c and heme b. This leads
us to suggest that reduction of the electron transfer hemes leads to an opening of the active site which allows
substrate to bind and in turn raises the reduction potential of the active site such that electrons are only
delivered to the active site following substrate binding.ces, University of East Anglia,
4 1603 592250.
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The respiratory nitric oxide reductases (NORs) are integral
membrane proteins found in bacteria that catalyse the reductive
condensation of two molecules of nitric oxide (NO) to form nitrous
oxide (N2O) [1,2]:
2NO þ 2Hþ þ 2e− → N2O þ H2O
This reaction is the third step in theprocess of bacterial denitriﬁcation
in which the soluble anions nitrate (NO3−) and nitrite (NO2−) are
converted enzymatically to nitrous oxide [3].
NO
−
3 → NO
−
2 → nitric oxideðNOÞ→ N2O→ N2
A fourth enzyme, nitrous oxide reductase, further reduces N2O to
dinitrogen which is released to the atmosphere. However, when
nitrous oxide reductase is absent or inactive the major product of
denitriﬁcation is N2O, a signiﬁcant greenhouse gas [4]. In recent
decades, the largest source of anthropogenic N2O emissions has been
agricultural soils, in part due to the increased use of artiﬁcial fertilisers
containing nitrates. Consequently there is a considerable interest in
enzymes, including the bacterial NOR, that are responsible for the
production and/or consumption of N2O.Three types of respiratory NORs have been described in Eubacteria
[2], and the X-ray structure of the cytochrome c dependent NOR
(cNOR) from Pseudomonas aeruginosa which is puriﬁed as a two-
subunit complex, NorBC, has been recently reported [5]. This will help
to interpret the detailed biochemical and spectroscopic information
that has been obtained on the NorBC from Paracoccus denitriﬁcans [1].
NorC is a mono-heme c-type cytochrome that possesses an N-
terminal transmembrane helix that anchors the heme domain to the
periplasmic face of the cytoplasmic membrane and relays electrons
from the periplasmic donor proteins (cytochromes and cupredoxins)
to the catalytic subunit, NorB [5,6]. While functionally distinct, NorB is
structurally related to the catalytic subunit (subunit I) of the
respiratory heme–copper oxidases (HCuOs), e.g. cytochrome aa3
oxidase [5,7]. NorB contains three metal centres, a magnetically
isolated heme known as heme b, a second heme, known as heme b3,
and a non heme iron (FeB) which is coordinated by three histidine
residues that are conserved in all typical HCuOs and a glutamate
residue that is conserved in all NORs [5]. Heme b3 and FeB form a
dinuclear centre at the active site of the enzyme and are close enough
to be magnetically coupled [8].
In the fully oxidised enzyme as isolated from P. denitriﬁcans the two
components of the dinuclear centre are linked by a μ-oxo bridge and
heme b3 lacks a proximal ligand [9]. Upon partial reduction the μ-oxo
bridge is broken and opens up the active site to binding of small
molecules e.g. CN− ions [10]. This change is reported by a shift in the
position of a ligand to metal charge transfer (CT) band associated with
ferric heme b3 in the UV–visible spectrum of NOR from 595 nm
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[10–12]. The shift is pH dependent and consistent with binding of
histidine as the proximal ligand to high-spin ferric heme b3 specieswith
distal ligation by OH− (605 nm) at pH 8.5 or H2O (630 nm) at pH 6.0
[11].
Mediated redox titrations of NorBC monitored using UV/vis
spectroscopy were used to assign reduction potentials to the four
metal centres of the enzyme at pH 7.6 [10]. Analysis of the absorbance
changes seen at 550 nm and 560 nm in response to changes in the
solution potential allowed the midpoint reduction potentials for the
low spin hemes c (+310 mV) and b (+345 mV) to be measured [11].
These hemes are predicted to accept electrons from periplasmic
donors, such as cytochrome c550 (Em=+256 mV) or pseudoazurin
(Em=+230 mV) and their recorded midpoint reduction potentials
are consistent with a role in facilitating rapid electron transfer.
The changes in absorbance due to the reduction of hemes b and c are
accompanied by changes in the near infrared region (590–640 nm) that
reﬂect changes at the dinuclear centre. Hence the reduction of NorBC
can also bemonitored by the decrease in absorbance at 595 nmwhich is
described by a two phase curve. At pH 7.6 partially reduced NorBC
contains a mixed population of His/OH− and His/H2O ligated ferric
heme b3. This means that the initial decrease of absorbance observed at
595 nm is accompanied by an increase in the 605 nm and 630 nm
features [11]. Further reduction of NorBC results in the complete loss of
these CT bands such that the second, lower potential, phase of the redox
titrationmonitored at 595 nm reports themidpoint reduction potential
of heme b3 (+60mV) [11].
Theﬁrst, higher potential, phaseof the titrationmonitored at595 nm
was interpreted in terms of reporting the reduction of the non heme FeB
which causes the μ-oxo bridge to break and the active site to open. This
part of the curve was used to determine a midpoint reduction potential
for the FeB centre (+230 mV), an analysis that led to the suggestion the
enzyme was active in a three electron reduced state. However a major
constraint on this interpretation is that the properties of the non heme
FeB were inferred from spectroscopic shifts due to ligation changes at
heme b3 rather than any change in the oxidation state of the non heme
FeB itself. This was necessary because the FeB centre in NOR is
spectroscopically silent. Weak signals that arise from non heme FeB in
the visible spectrum of NorBC are masked by the intense signals of the
hemes and the characteristic signal in the EPR spectrum of a ferric
mono-nuclear non-heme iron centre at g′=4.3 is rendered silent due to
coupling to the heme b3 [8]. In the presentworkwe present amethod to
spectroscopically isolate and probe the nature of the FeB site, which
allows a re-appraisal of earlier spectro-potentiometic studies.
2. Materials and methods
2.1. Cell growth and puriﬁcation
NorBC used in this study was puriﬁed from P. denitriﬁcans strain
93.11 (ΔctaDI, ΔctaCII, qoxB::kanR) grown in a Bioengineering 100-litre
fermenter or 8×5-litre Duran ﬂasks in minimal medium under
anaerobic denitrifying conditions. The enzymewaspuriﬁedasdescribed
by Field et al. [13].
2.2. Spectroscopy
Electronic absorption spectrawere recordedon aVarian Cary 50 BIO,
an Aminco DW2000 or a JASCO V-500 UV–visible spectrophotometer.
The concentration of NorBC was calculated using an extinction
coefﬁcient ε411=3.11×105 M−1 cm−1 [12].
EPR spectra were recorded on either a Bruker ELEXSYS 500
spectrometer with an ER049X SuperX microwave bridge and an SHQ
cavity or on an X-band ER200-D spectrometer (Bruker Spectrospin)
interfaced to an ESP1600 computer. Low temperature experiments wereperformed using an Oxford Instruments ESR-900 helium cryostat and
ITC3 temperature controller.
2.3. Electrodic poising of NorBC for EPR spectroscopy
All manipulations were carried out in an anaerobic glove box (Belle
Technology) under a N2 atmosphere and at 4 °C. Samples of NorBC at a
concentration of 135 μM in 20 mM BTP, 50 mM NaCl, 0.02% (wt./vol.)
dodecyl-β-D-maltoside (DDM) adjusted to either pH 6.0 or pH 8.5 as
desired were supplemented with the following redox mediators at a
ﬁnal concentration of 10 μM;Dichlorophenol (+217 mV), trimethylhy-
droquinone (+100 mV), phenazine methyl sulphate (+80 mV), 5-
hydroxynapthoquinone (+45 mV), duroquinol (0 mV), menadione
(−80 mV), 9,10-anthraquinone-2,6-disulfonic acid (−185 mV), safra-
nine (−289 mV), and benzyl viologen (−350 mV). Samples were
poised at a deﬁned potential using a three-electrode cell conﬁguration
incorporating an Al2O3 polished carbon ‘pot’ working electrode. The
reference electrode was calomel in saturated KCl, (SCE) and this
contacted the sample via a Luggin tip. The counter electrode was a Pt-
wire physically separated from the sample by a Vycor frit. The potential
was controlled and the resulting ﬂow of current measured by a PGSTAT
12 potentiostat (Autolab) controlled by GPES software. Samples were
stirredduring poising and equilibriumwas judged to have been reached
when the monitored current fell to zero. Equilibrated samples were
transferred to EPR tubes in the glove box, the tubes were sealed and the
samples frozen in liquid nitrogen within 1 minute. Experimental
potentials were referenced to the SHE by the addition of 241 mV.
2.4. Preparations of partially reduced forms of NorBC in a CO environment
Chemical titrations under an atmosphere of CO were carried out in
an anaerobic glove box (Belle Technology) under a N2 atmosphere
using EuCl2:EGTA as the reductant [14]. Titrations were monitored
with a voltmeter at 4 °C in a water jacketed glass cell ﬁtted with ports
for an SCE, a platinum wire counter electrode, a glass bulb ﬁlled with
CO and a needle to allow the injection of reductant. NorBC samples in
the concentration range 50–60 μM were buffered in 20 mM BTP,
50 mMNaCl, 0.02% (wt./vol.) DDM pH 6.0 and supplemented with the
mediator cocktail described in Section 2.3. Once the required potential
was reached samples were transferred to EPR tubes in the glove box,
the tubes were sealed and the samples frozen in liquid nitrogen
within 1 minute.
2.5. Spectroelectrochemical titrations of NorBC
Reductive titrations of NorBC using sodium dithionite were carried
out at 20 °C essentially as describedbyDutton [15]. Samples ofNorBC (5–
20 μM)were prepared in 20 mMBis–Tris–propane (BTP), 340 mMNaCl,
0.02% (wt./vol.) DDM, adjusted to a known pH in the range 6.0–8.5
supplemented with the following cocktail of redox mediators at a ﬁnal
concentrationsof 20 μM:Diaminodurene (+240 mV), phenazinemethyl
sulphate (+80 mV), phenazine ethyl sulphate (PES) (+55mV), 5-
hydroxynapthoquinone (+45 mV), 6-anthraquinone-2,6-disulfonic acid
(−184 mV), 5-anthraquinone-2-sulfonic acid (−230 mV) and benzyl
viologen(−350 mV).Quinhydrone (Em,pH 7.0=+295 mV)wasusedasa
redox standard.
2.6. Electrodic titrations of NorBC under a CO atmosphere
These experiments were performed in a 10 mm path length cuvette
which accommodated aplatinum foilworking electrode, gas inlet andCO
bulb attachment. The counter electrode was a platinum wire separated
from the sample by a Vycor frit. An Ag/AgCl reference electrode was
connected via a luggin tip. Samples of NorBC (20 μM) were prepared in
20 mM BTP, 100 mM NaCl, 0.02% (wt./vol.) DDM, pH 6.0. Redox
mediators were included in the sample at ﬁnal concentrations of 40 μM
453S.J. Field et al. / Biochimica et Biophysica Acta 1807 (2011) 451–457as follows; ferrocene acetic acid (+365 mV), diaminodurene
(+240 mV), ruthenium hexamine chloride (+200mV), trimethylhy-
droquinone (+100 mV), 5-hydroxynapthoquinone (+45 mV), duro-
quinol (0 mV), menadione (−80 mV), 9,10-anthraquinone-2,6-
disulfonic acid (−185 mV), and 5-anthraquinone-2-sulfonic acid
(−230 mV). The spectroelectrochemical cell containing the sample
was spargedwithnitrogengas thenwithCOgas andabulb containingCO
gaswas attached to the cell in order tomaintain a constant atmosphere of
CO during the experiment. The desired potential was applied to the cell
using a PGSTAT 12 potentiostat controlled by GPES software (Autolab).
The samples were stirred and equilibrium was judged to have been
reached when the monitored current fell to zero. Recorded potentials
were referenced to the SHE by the addition of 197 mV.
3. Results and discussion
3.1. Potential dependent changes in the X-band EPR spectrum of NorBC
To investigate the redox properties of the non-heme Fe centre of
NorBC, continuous wave X-band EPR spectra were collected from
samples poised electrodically at a range of potentials. At pH 6 the EPR
spectrum of the as prepared fully oxidised NorBC is as previously
described [12] (Fig. 1). Two features typical of low spin, S=1/2, hemes
are visible in the spectrum, the rhombic trio (gx, gy, and gz,=3.00, 2.25
and 1.46), and high gmax species, gz=3.55, have previously been
assigned to the low spin heme b and heme c respectively [12]. The signal
seen at g=2.01 has previously been attributed to a trace of a
contaminating [3Fe-4S] cluster [12]. The heme b3 and non heme FeB in
the active site of NorBC have been shown to be anti-ferromagnetically
coupled, leading to the absence of EPR signals from these metal centres
[8]. Peaks seen in the g=6 and g=4.3 regions of the pH 6.0 spectrum
where signals from these centres are expected to arise are thought to be
due to small populations of protein (b5%) where the dinuclear centre is
uncoupled [8]. After reducing the sample to +100 mV, EPR signals due
to the low spin hemes b and c disappeared, consistent with these being
high-potential centres [11]. The residual signal at g=3.01 is of a slightly
different line shape to that seen in the oxidised spectrum and has
previously been attributed to a small amount of uncoupled low spin
heme b3 in the partially reduced NorBC [13].
The spectra of NorBC samples poised at potentials below+100 mV
showed little change of the signals in the g=6 and g′=4.3 regions,Fig. 1. Changes in the X-band EPR spectrum of NorBC as a function of solution potential.
Samples were prepared as described in Section 2.1 and EPR spectra subsequently
recorded at 10K using the following conditions: microwave frequency of 9.44 GHz,
microwave power of 2 mA and a modulation amplitude of 1 mT. Panel A: NorBC
(135 μM) in 20 mM BTP, 50 mM NaCl, 0.02% (wt./vol.) DDM, pH 6.0. Panel B: NorBC
(135 μM) in 20 mM BTP, 50 mM NaCl, 0.02% (wt./vol.) DDM, pH 8.5.where heme b3 and non-heme iron, respectively, are expected to be
detected (Fig. 1). This is signiﬁcant because if the FeB has a midpoint
reduction potential close to those of the low spin heme b and heme c,
as inferred from previous UV–visible potentiometric titrations [11,12],
then as the titration proceeds the signal at g=6, from the heme b3,
should become increasingly intense as the ferric FeB becomes reduced
and the coupling between heme b3 and FeB is broken. That this does
not happen suggests that the midpoint reduction potentials of heme
b3 and FeB are similar. Close examination of the spectra in the g=6
and g′=4.3 regions shows that a small increase followed by a
decrease is seen in each of the g=6 and g′=4.3 signals. This is
consistent with an electron reducing one site or the other site in the
enzyme population to yield small populations of EPR-visible heme b3
(II) FeB(III) or heme b3(III) FeB(II) centres, before full reduction to a
homogenous all ferrous state occurs as expected if the reduction
potentials of heme b3 and FeB are near iso-potential. At pH 8.5
(Fig. 1B), signals which arise from the low spin hemes b and c again
both disappear at +100 mV. The midpoint reduction potential of the
FeB at pH 8.5 appears to be slightly higher than that of the heme b3;
something that is suggested by the slight increase in the intensity of
the ferric heme b3 signal in the g=6 region of the EPR spectra. Overall
though, the data shows that the reduction potential of both metals in
the active site of NorBC are at a signiﬁcantly lower reduction potential
then that of the electron receiving/storage hemes, heme c and heme b.3.2. The X-band EPR spectrum of the non-heme iron FeB
In an attempt to isolate the non-heme iron centre spectroscopically
and so obtain direct insight into its redox properties the fact that CO,
which is neither paramagnetic nor a substrate for the enzyme, will
stabilise the reduced state of heme b3 by forming a His/CO co-ordinated
species was exploited [16]. EPR spectra were collected from samples of
NorBCpoised at a rangeof potentials under anatmosphere of CO(Fig. 2).
As the sample potential was lowered the spectrumbecomes dominated
by a large axial signal at g′=4.3 that is characteristic of a high spin,
S=5/2, ferric non heme iron in a low-symmetry environment [17].
Similar spectra have been described in other non heme iron containing
proteins, for example transferrin [18] and protocatechuate dioxygenase
[19]. The increase in the g′=4.3 signal, which is attributed to
magnetically isolated ferric FeB, reaches a maximum at +290 mV.
These data are consistentwith the suggestion that in the presence of CO
the effectivemidpoint reduction potential of heme b3 increases so that itFig. 2. The X-band EPR spectrum of chemically reduced NorBC in the presence of CO.
Sample of NorBC (50–60 μM) in 20 mM BTP, 50 mMNaCl, 0.02% (wt./vol.) DDM, pH 6.0.
The spectra were recorded at 10K using the following conditions: a microwave
frequency of 9.44 GHz, microwave power of 2 mA and a modulation amplitude of 1 mT.
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reduction of the dinuclear centre is to break the coupling between ferric
heme b3 and ferric FeB allowing the EPR spectrumof FeB(III) to be clearly
resolved. Reduction to +11mV results in complete loss of the FeB(III)
signal, suggesting that the presence of CO in the active site also raises the
midpoint reduction potential of the FeB(II/III) couple. The increase in
midpoint reduction potential of FeB leads to an overlap of the potential
ranges inwhich the heme b3 and FeB become reduced. Consequently the
signal seen at +290 mV is not representative of 100% ferric FeB for two
reasons. Firstly at +290 mV the heme b3 is not fully reduced (see
Section3.4); hence, a proportion of the active site remains fully oxidised,
coupled and retaining an EPR silent ferric FeB. Secondly it is conceivable
that themidpoint reduction potential of FeB is raised sufﬁciently under a
CO atmosphere such that it starts to become reduced before the whole
population is released from the coupling with heme b3. Integration of
EPR signals at g′=4.3 arising from a high spin, S=5/2, non heme iron
centres is problematic due to the low symmetry of the signals and
therefore we are unable to determine the midpoint reduction potential
of the non heme FeB.
3.3. Spectroelectrochemical titrations of NorBC
In the light of the EPR data identifying the FeB(III) signal in heme
b3–CO complexed active site and suggesting a low midpoint potential
for FeB in the CO-free enzyme, a series of visible spectropotentio-
metric titrations was undertaken in the pH range 6.5–8.5.
Previous analysis of data collected at pH 7.0 described the loss of
absorbance at the 595 nm that is associated with complete reduction
of the enzyme in terms of three independent n=1 Nernstian curves
[11]. The ﬁrst two phaseswere interpreted in terms of reduction of FeB
causing the μ-oxo bridge at the dinuclear centre to break yielding a
“three-electron reduced” form of the enzyme in which ferric heme b3Fig. 3. Spectroelectrochemical titration of NorBC. A representative reductive titration of No
described in Section 2.4. Panel A: Spectral changes associated with the reduction of NorBC are
every other aliquot of sodium dithionite are shown. Panel B: The loss of absorbance at 595 nm
(n=1) Nernstian curves that report the formation of His/OH− ligated ferric heme b3 (Em,6.5=
the loss of the 630 nm CT band in response to reduction. Panel D: The loss of absorbance at 63
Nernstian curve (Em,6.5=+82 mV) that reports the reduction of heme b3.exists as amixture of the His/H2O and His/OH− ligated forms [10]. The
ﬁnal phasewas attributed to the subsequent reduction of the heme b3.
In the present study, it is instructive to consider the titration carried
out at pH 6.5 (Fig. 3). At this pH the 630 nm CT band (Fig. 3C) persists
after the loss of the 595 nm band indicating that the heme b3 remains
oxidised and hasHis/H2O ligation at this point in the titration. Hence the
midpoint reduction potential for the heme b3 will be obtained by
following the loss of intensity at 630 nm as a function of solution
potential. Analysis of this titration gives the midpoint reduction
potential for the heme b3 at pH 6.5 to be Em,6.5=+82mV (Fig. 3D). If
the oxidised, and presumably high-spin heme b3, that gives rise to the
630 nm band, was the only remaining oxidised centre in the protein
then it would be represented in the EPR spectrum at solution potentials
N+100 mV by a large signal at g=~6.0. This is clearly not the case
(Fig. 1) because the ferric heme b3 remains magnetically coupled to the
ferric non heme iron and therefore EPR silent.
The midpoint reduction potentials of all three hemes in NorBC are
relatively insensitive to changes in pH for the range pH 6.0–8.5 (Fig. 4
and Table 1). However careful examination of the data reveals that in
fact it is the oxidation state of the low spin heme b, and not FeB, that
inﬂuences the ligation state of the ferric high spin heme b3 and hence
the accessibility of the active site to substrate. For example, at pH 8.5
and 7.5, the reduction potential of heme b can be obtained by ﬁtting
the increase in absorbance at 560 nm to a single n=1 Nernstian
curve. This gives midpoint reduction potentials for this centre of
Em,8.5=+250 mV and Em,7.5=+282 mV at pH 8.5 and 7.5 respec-
tively. These values are in good agreement with the midpoint
reduction potentials obtained from ﬁtting the ﬁrst phase of the loss
of absorbance at 595 nm band at pH 8.5 and 7.5; Em,8.5=+242 mV
and Em,7.5=+271 mV. This suggests that the reduction of the low
spin heme b can be monitored in two ways, either by the increase in
absorbance at 560 nm or by the initial loss of absorbance at 595 nm.rBC (10 μM) in 20 mM BTP, 340 mM NaCl, 0.02% (wt./vol.) DDM, pH 6.5 carried out as
indicated by arrows. In the interests of clarity only spectra recorded after the addition of
(■) plotted as a function of solution potential. The solid line is a ﬁt to two independent
+215 mV) and His/H2O ligated ferric heme b3 (Em,6.5=+320 mV). Panel C: Details of
0 nm (■) plotted as a function of solution potential. The solid line is a ﬁt to a single n=1
Fig. 4. The pH dependence of the observedmidpoint reduction potentials of the hemes in
NorBC. Midpoint potentials were determined from a series of spectroelectochemical
titrations as described in Section 2 and plotted as function of pH as follows. Heme c
(■) determined fromthe change in absorbance at 551 nm.Heme bﬁrstmidpoint potential
(♦) and second midpoint potential (◊) determined from the change in absorbance at
560 nm. Heme b (ﬁrst midpoint potential) determined from the formation of His/OH−
ligated ferric heme b3 (●). Heme b (second midpoint potential) determined from the
formation of His/H2O ligated ferric heme b3 (○). Midpoint reduction potential of heme b3
determined from the change in absorbance at 595 nm (▲).
455S.J. Field et al. / Biochimica et Biophysica Acta 1807 (2011) 451–457The initial loss of absorbanceat 595 nmassociatedwith the reduction
of heme b coincides with a shift in the CT band to a longer wavelength
which reports the breaking of the μ-oxo bridge and gives information on
the subsequent ligation to ferric heme b3. This clearly indicates that
reduction of the low spin heme b leads to a change in coordination of
ferric heme b3 fromtheμ-oxobridged form inwhich thedinuclear centre
is closed, to a His/OH− form in which the dinuclear centre is open and
can bind exogenous ligands. It has previously been reported that, below
pH 7.5, partial reduction of NorBC results in two heme b3 species, one
population with His/OH− ligation and a second with His/H2O ligation
[10]. This is reﬂected in the requirement for a two phase ﬁt to the data
obtained from monitoring the increase in absorbance at 560 nm
associated with the reduction of heme b at pH 6.5. The high potential
phase of reduction is concomitant with a change of ligation from a μ-oxo
bridged active site toHis/H2O ligation of theheme b3, Em,6.5=+290 mV.
The low potential phase pertains to the reduction of the heme b when
the μ-oxo bridge breaks to form a His/OH− ligated heme b3, Em,6.5=
+225mV. These potentials are very close to those obtained from the
ﬁrst two phases associated with the loss of the 595 nm band at pH 6.5
which give midpoint reduction potentials for the reduction of heme b
and the associated ligation change at the heme b3 to His/OH of Em,6.5=
+ 215 mV and to His/H2O of Em,6.5=+320 mV.Table 1
Effect of pH and CO exposure on the midpoint reduction potentials of the hemes in NorBC.
Em (mV)
pH Heme c (551 nm) Heme b
First midpoint
potential (560 nm)
Heme b
Second midpoint
potential (560 nm
8.5 230 250
7.5 250 282
7.0 276 290 315
6.5 250 225 290
6.0 (under CO atmosphere) 273 297
a Determined at 595 nm.
b Determined at 640 nm.Taken together these data strongly suggest that the reduction of
the low spin heme b causes the proximal histidine (His-334) to ligate
the active site heme b3 and cause the μ-oxo bridge to break. This
proposal is broadly consistent with the recently published structure of
the P. aeruginosa enzyme which is in the half-reduced state due to the
very rapid reduction of the high potential hemes, heme c and heme b,
in the X-ray beam [5]. It is also perhaps not too surprising since the
structure of NorB also shows that the axial ligand to heme b (His-336)
and the proximal ligand to heme b3 (His-334) are on opposite faces of
transmembrane helix 10 [5]. The intervening residue is a glycine (Gly-
335) which might suggest some conformational ﬂexibility in this
region of the helix.
3.4. The effect of CO on the midpoint reduction potential of heme b3
Spectroelectrochemical titrations of NorBC collected under an
atmosphere of CO revealed that as the potential is reduced signals in
the α and β regions increase in intensity as the low spin hemes b and c
become reduced (Fig. 5A). The changes in absorbance at 551 nm and
560 nm can be plotted against potential and ﬁtted to n=1 Nernstian
curves (Fig. 5B and C) to give midpoint reduction potentials for the low
spin hemes b and c under a CO atmosphere of +297 mV and+273 mV
respectively. These values are in good agreement with those seen for
these centres without CO present and using a chemical reductant,
suggesting that neither the manner of reduction nor presence of a
substrate analogue has a signiﬁcant effect on their reduction potential.
Simultaneously, intensity is completely lost from the 595 nm CT
band arising from the oxidised, μ-oxo bridged, heme b3 as this centre
also becomes reduced. This is in contrast to the situation during
titrations without CO present where the CT band shifts to longer
wavelengths on the reduction of the low spin hemes before the heme b3
becomes reduced at lower potential (Fig. 3A). Consequently, the change
in absorbance at 595 nm can be ﬁtted to a single n=1 Nernstian curve
giving a midpoint reduction potential for the heme b3 of +303 mV
under a CO atmosphere (Fig. 5D). This shift to higher potential of over
200 mV in response to thepresence of CO is comparable to that reported
for the active site heme o3 in a form of the canonical HCuO cytochrome
bo3 oxidase that lacks CuB in its dinuclear centre [20] In the case of the
active site of NorBC the increase in the reduction potential of the
catalytic heme elicited by the presence of CO raises it to the region in
which the electron transfer hemes become reduced.
4. Conclusions
We have shown that the redox centres at the active site of NorBC
are at isopotential with midpoint reduction potentials of
Em≈+80 mV. Given that these values lie below those of hemes b
and c at ca. +300 mV it would appear that heme c and heme b act as
an electron receiving/storage module and that in the absence of
substrate the active site does not become substantially reduced on
reduction of both the low spin hemes b and c. However, reduction of
the low spin heme b leads to breaking of the μ-oxo bridge in the)
Heme b
First midpoint potential
(595 nm) heme b3 forms His/OH−
Heme b
Second midpoint potential
(560 nm) heme b3 forms His/H2O
Heme b3
242 a82
271 a80
248 328 a86
215 320 b79
a303
Fig. 5. The effect of CO on the midpoint reduction potential of heme b3. Spectral changes in NorBC (20 μM) in 20 mM BTP, 100 mM NaCl, 0.02% (wt./vol.) DDM, pH 6.0 under an
atmosphere of CO were recorded as a function of solution potential as described in Section 2.6. Panel A: Representative spectra recorded during reductive (solid line) and oxidative
(dashed line) titrations. Panel B: Changes in absorbance at 560 nm associated with oxidation/reduction of heme b plotted as function of solution potential. The data points were
recorded either during reductive (■) or oxidative (▲) titrations and the solid line is a ﬁt to a n=1 Nernstian curve (Em,6.0=+ 297 mV). Panel C: Changes in absorbance at 551 nm
associated with oxidation/reduction of heme c plotted as function of solution potential. The data points were recorded either during reductive (■) or oxidative (▲) titrations and the
solid line is a ﬁt to a n=1 Nernstian curve (Em,6.0=+273 mV). Panel D: Changes in absorbance at 595 nm associated with oxidation/reduction of heme b3 plotted as function of
solution potential. The data points were recorded either during reductive (■) or oxidative (▲) titrations and the solid line is a ﬁt to a n=1 Nernstian curve (Em,6.0=+303 mV).
Fig. 6. Schematic diagram showing a possible mechanism reductive activation and
electron transfer in NorBC. A shows the μ-oxo bridged dinuclear centre in the as isolated
protein. B shows the opening of the active site and binding of the proximal histidine to
heme b3 upon reduction of the low spin heme b. C shows the CO bound species after
electron transfer to the active site and re-reduction of heme b by heme c.
456 S.J. Field et al. / Biochimica et Biophysica Acta 1807 (2011) 451–457oxidised dinuclear centre and in turn leads to the opening of the active
site to allow binding of substrate molecules (Fig. 6B). In the presence
of CO, a substrate analogue, the reduction potential of the heme b3 is
raised sufﬁciently to initiate proton-coupled electron transfer to the
active site. It is conceivable that binding of the natural substrate, NO,
to heme b3 would elicit the same effect. (Fig. 6C). Thus, we postulate
that reduction of the electron transfer hemes leads to an opening of
the active site which allows access to substrate which in turn raises
the reduction potential of the active site heme b3 such that electrons
are only delivered to the active site when substrate is present and able
to form a ferrous-NO heme b3 species.
The participation of such an intermediate would be consistent
with the results obtained in a recent study of the reaction of fully
reduced NorBC with NO using the ﬂow–ﬂash approach [21]. In this
experiment the four-electron reduced enzyme is able to complete two
turnovers; the ﬁrst turnover using the electrons in the active site and
the second using the electrons stored by heme c and heme b.
Consequently the second turnover must involve electron transfer to
the active site in the presence of substrate. The rate of electron
transfer to the active site is clearly dependent on the concentration of
NO, with the rate of internal electron transfer increasing as the NO
concentration is lowered [21]. This is consistent with an earlier report
of substrate inhibition of NorBC [22] and reports of the steady state
concentration of NO in cultures of actively denitrifying P. denitriﬁcans
being as low as 20 nM [23] which is still considerably higher than the
KD (1×10−12 M) for NO binding to the ferrous heme b in myoglobin
[24].
Previous consideration of the mechanism of NO reduction by the
bacterial NOR has focussed onwhether one or bothmetal centres in the
active site bind substrate molecules. In the so-called cismechanism it is
envisaged that both NO molecules bind to FeB [25], while in the trans
mechanism one NOmolecule would bind to FeB and the other to heme
457S.J. Field et al. / Biochimica et Biophysica Acta 1807 (2011) 451–457b3 [9,26]. Until recently less emphasis has been given to the way in
which the enzyme orchestrates the arrival of its co-substrates, 2NO, two
electrons and twoprotons, at the active site tominimise the opportunity
for unwanted reactions. The results presented here seem to argue that
initial binding of theﬁrstNOmoleculewouldbe to theoxidisedhemeb3,
something that would exclude the cis mechanism and be consistent
with computational studies [27], which suggest that the role of FeB is to
stabilise a hyponitrite intermediate. Further experiments will be
required in order to determine if the second molecule of NO binds to
FeB or if reacts directly with the NO bound to the heme b3 to form the
hyponitrite intermediate which then decomposes to form the product,
N2O and possibly reform the μ-oxo bridge.
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